All Pharmaceuticals articles
-
News BriefTrump picks Dr. Oz to run massive Medicare, Medicaid agencies
Dr. Mehmet Oz, President-elect Donald Trump’s pick to lead the Centers for Medicare and Medicaid Services, has a mandate from Trump to “take on the illness industrial complex” and to cut costs.
-
News BriefDrug company and CEO pay $47 million over alleged kickbacks and false claims
A pharmaceutical company and its chief executive have agreed to pay $47 million to settle allegations first brought by whistleblowers, that the company paid kickbacks and filed false claims, the Department of Justice said.
-
Blog
Kailera Therapeutics welcomes legal chief
Biopharmaceutical company Kailera Therapeutics announced the appointment of Scott Akamine as chief legal officer.
-
PremiumSpeakers at Compliance Week AI & Compliance Summit talk future rules around technology
While companies are exploring and building artificial intelligence technology, lawmakers and regulators are trying to identify what ground rules they need to set. These guardrails are what companies and governments alike believe are essential parts of ensuring safe and responsible use of the technology.
-
PremiumHow to adopt AI tools the right way at your company, from people who’ve tried
Companies are adopting artificial intelligence tools at a breakneck pace, but it’s increasingly clear that they set guardrails early. AI leaders say that approaching the technology with safety and ethics in mind will help ensure its upside benefits, while avoiding the significant risks it poses as well.
-
News BriefTeva Pharma to pay $450M to settle kickback, price-fixing allegations
Generic drug giant Teva Pharmaceuticals has agreed to pay $450 million to settle two cases brought by the Department of Justice (DOJ), including one alleging that co-pays it made on behalf of Medicare patients constituted illegal kickbacks, and a second action for alleged generic drug price fixing.
-
Blog
Oculis announces chief legal officer
Biopharmaceutical company Oculis Holding AG announced the appointment of Daniel Char to the role of chief legal officer.
-
News BriefCassava Sciences settles with SEC for $40M over skewed Alzheimer’s drug data
A former Alzheimer’s researcher manipulated the results of a Cassava Sciences drug, with the pharmaceutical company and its former chief executive reaching a $40 million settlement with the Securities and Exchange Commission over allegedly misleading the public.
-
Blog
Morris & Dickson announces compliance chief
Pharmaceutical distributor Morris & Dickson announced that Vinu Pillai has joined the company as its chief compliance and regulatory officer.
-
News BriefDOJ orders Walgreens to pay $107M for fraudulent claims caused by Rx ‘software error’
Walgreens agreed to pay nearly $107 million to resolve allegations, first brought by two whisteblowers, that it improperly billed federal healthcare programs for prescriptions that were never picked up or delivered.
-
News BriefSEC charges three Medly execs with fraud for investment scheme
Former executives of Medly, an online pharmacy that is now shuttered, have been charged by the Securities and Exchange Commission with defrauding investors.
-
Blog
Terns Pharmaceuticals appoints legal chief
Terns Pharmaceuticals announced the appointment of Elona Kogan as chief legal officer.
-
Blog
PharmaEssentia appoints legal head
PharmaEssentia USA announced the appointment of Beth Krewson as head of legal.
-
Blog
HanAll Biopharma appoints legal chief
HanAll Biopharma announced the appointment of Christopher Slavinsky as chief business development and legal officer.
-
News BriefDOJ orders DaVita to pay $34M over alleged dialysis center kickback scheme
DaVita, a multi-state dialysis provider, agreed to pay more than $34 million to resolve allegations it engaged in numerous kickback schemes to doctors who referred Medicare patients to its dialysis centers, the Department of Justice announced.
-
News BriefRite Aid reaches $410M settlement with DOJ in opioid false claims case
Rite Aid agreed to pay $7.5 million and allow the Department of Justice to access nearly $402 million from the company’s forthcoming bankruptcy case to settle allegations it helped fuel the nation’s opioid epidemic.
-
Blog
AVITA Medical appoints legal, compliance chief
AVITA Medical announced the appointment of Nicole Linda Kelsey as chief legal and compliance officer and corporate secretary.
-
Blog
OnKure appoints general counsel
Biopharmaceutical company OnKure announced the appointment of Rogan Nunn as general counsel and secretary.
-
Blog
Kriya appoints chief legal officer
Biopharmaceutical company Kriya Therapeutics announced the appointment of Katherine Eade to the position of chief legal officer.
-
News BriefOFAC sanctions drug cartel over China procurement; FinCEN issues advisory
The Treasury Department’s Office of Foreign Assets Control and Secretary Janet Yellen announced sanctions Thursday against the top leaders of La Nueva Familia Michoacana drug cartel over the illicit trafficking of synthetic opioid fentanyl in the United States.